Cipla, Macleods HIV child treatments approved in South Africa
New Delhi: South Africa, which has the world's biggest number of people infected with HIV, has approved Cipla Ltd.'s quadrimune, a treatment for children infected with the virus, for use.
Quadrimune comes in the form of sweet-tasting granules that can be sprinkled on soft food or dissolved in mill or water, the South African Health Products Regulatory Authority said in a statement on Friday.
The treatment combines four antiretroviral treatments.
Read also: Cipla, DNDi unveil 4-in-1 ARV formulation for kids with HIV
Dolutegravir tablets, made by Macleods Pharmaceuticals Ltd., for the treatment of children with HIV, were also registered for use.
About 13% of South Africa's population, or 8.2 million people, are infected with HIV, according to the national statistics agency.
Read also: Cipla to purchase 21.05 percent stake in Achira Labs to develop affordable medical kits in India
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.